申请人:The Dupont Merck Pharmaceutical Company
公开号:US05411977A1
公开(公告)日:1995-05-02
The present invention relates to substituted 2, 5-diaryl-4-isothiazolin-3-ones, pharmaceutical preparations containing them, and their use in the treatment of, thrombosis and, especially inflammation.
本发明涉及取代的2,5-二芳基-4-异噻唑啉-3-酮、含有它们的药物制剂以及它们在治疗血栓形成和尤其是炎症方面的用途。